Traveller's diarrhoea vaccine transdermal - Valneva USA

Drug Profile

Traveller's diarrhoea vaccine transdermal - Valneva USA

Alternative Names: Escherichia coli vaccine transdermal - Valneva USA; ETEC vaccine - Valneva USA; Prophylactic TD vaccine patch; Transcutaneous ETEC vaccine - Valneva USA; Vaccine patch for traveller's diarrhoea - Valneva USA

Latest Information Update: 12 Dec 2017

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Iomai Corporation
  • Developer Intercell USA
  • Class Adjuvants
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Discontinued Escherichia coli infections; Traveller's diarrhoea

Most Recent Events

  • 11 Dec 2017 Intercell USA is now called Valneva USA
  • 13 Dec 2010 Discontinued - Phase-III for Escherichia coli infections in European Union (Transdermal)
  • 12 Dec 2010 Discontinued - Phase-II for Escherichia coli infections in India (Transdermal)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top